All Stories

  1. Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice
  2. Cardiometabolic health in people with HIV: expert consensus review
  3. Immunological alterations with GLP‐1 agonists in people living with HIV
  4. Evaluation of Self-Collected Versus Health Care Professional (HCP)-Performed Sampling and the Potential Impact on the Diagnostic Results of Asymptomatic Sexually Transmitted Infections (STIs) in High-Risk Individuals
  5. Seroconversion rate of SARS-CoV-2 IgG antibodies and dating behaviour in HIV-PrEP users in a German metropolis during the COVID-19 pandemic
  6. Long-acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 (HIV-1) Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-label, Phase 3b, Noninferiority Study
  7. Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
  8. Clinical characteristics of monkeypox virus infections among men with and without HIV : A large outbreak cohort in Germany
  9. Monkeypox in Germany
  10. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
  11. Clinical and virological features of first human monkeypox cases in Germany
  12. Clinical and virological features of first human Monkeypox cases in Germany
  13. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
  14. The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study
  15. Inadequate PTH-Response to Hypocalcemia in People Living with HIV
  16. Humoral response to SARS-CoV-2 vaccines in people living with HIV
  17. Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infection
  18. HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German ‘hotspot’
  19. Antivirale Therapie der Zukunft: Was ist in der Pipeline?
  20. Risk factors for bleeding from gastrointestinal angiodysplasia: a case-control study in patients with bleeding and non-bleeding angiodysplasia
  21. HIV and SARS-CoV-2 Coinfection - Cross-Sectional Findings from a German 'Hotspot'
  22. Not all is perfect with Tenofovir alafenamide
  23. Influence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV
  24. Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis
  25. Tenofovir disoproxil fumarate/emtricitabine is associated with a higher risk of hypocalcemia compared to abacavir/lamivudine – results from a German cohort study
  26. Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort
  27. Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study
  28. Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing’s syndrome
  29. Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study
  30. Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study
  31. Patterns of vitamin D, parathyroid hormone and c-terminal telopeptide of collagen type 1 in Caucasian and African descent HIV-infected populations in Central Europe
  32. Depotspritze gegen HIV
  33. Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study
  34. Medikamentöse Therapie neuroendokriner Neoplasien
  35. Fatal Systemic Vasoconstriction in a Case of Metastatic Small-Intestinal NET
  36. Corrigendum to “Fatal Systemic Vasoconstriction in a Case of Metastatic Small-Intestinal NET”
  37. Applicability of stroke volume variation in patients of a general intensive care unit: a longitudinal observational study
  38. International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK
  39. Dynamics of Adrenocorticotropin after Application of Metyrapone
  40. Dynamics of adrenocorticotropin after stimulation with metyrapone (DYNAMO)
  41. Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study
  42. Are selected IL-1 polymorphisms and selected subgingival microorganisms significantly associated to periodontitis in type 2 diabetes patients? a clinical study
  43. 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada
  44. Fungal “colonisation” is Associated with Increased Mortality in Medical Intensive Care Unit Patients with Liver Cirrhosis
  45. Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report
  46. Neuroendokrine Tumoren des Verdauungstrakts – Daten des deutschen NET-Registers
  47. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
  48. Postendoscopic retrograde cholangiopancreatography pancreatitis
  49. Klinik und Diagnostik neuroendokriner Neoplasien